StonvexLoading…
StonvexStonvexStonvexCore line items from MREO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $500.00K | $0.00 | $10.00M | $0.00 |
Operating Income | $-40.11M | $-47.36M | $-28.42M | $-54.43M |
Net Income | $-41.88M | $-43.25M | $-29.47M | $-42.22M |
EPS (Diluted) | $-0.05 | $-0.06 | $-0.04 | $-0.07 |
Total Assets | $45.92M | $76.39M | $66.50M | $77.41M |
Total Liabilities | $5.00M | $15.42M | $15.96M | $26.01M |
Cash & Equivalents | $40.99M | $69.80M | $57.42M | $68.18M |
Free Cash Flow OCF − CapEx | $-30.99M | $-32.83M | $-21.13M | $-48.83M |
Shares Outstanding | 797.12M | 739.62M | 659.45M | 603.20M |